TipRanks
MacroGenics (DE:M55)
FRANKFURT:M55
Germany Market
M55
MacroGenics
RESEARCH TOOLSreports

MacroGenics (M55) Stock Forecast & Price Target

5 Followers
See the Price Targets and Ratings of:

M55 Analyst Ratings

Moderate Buy
4Ratings
Moderate Buy
2 Buy
2 Hold
0 Sell
Based on 4 analysts giving stock ratings to
MacroGenics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

M55 Stock 12 Month Forecast

Average Price Target

€6.04
▲(66.89% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for MacroGenics in the last 3 months. The average price target is €6.04 with a high forecast of €9.49 and a low forecast of €3.45. The average price target represents a 66.89% change from the last price of €3.62.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","5":"€5","10":"€10","2.5":"€2.5","7.5":"€7.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9.49366,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€9.49</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.04142,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€6.04</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.45224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€3.45</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.5,5,7.5,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,3.868743076923077,4.337486153846154,4.8062292307692305,5.274972307692307,5.743715384615385,6.2124584615384615,6.681201538461538,7.149944615384616,7.618687692307692,8.08743076923077,8.556173846153847,9.024916923076923,{"y":9.49366,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,3.6031861538461536,3.8063723076923077,4.009558461538461,4.212744615384615,4.415930769230769,4.619116923076923,4.822303076923077,5.025489230769231,5.228675384615384,5.431861538461538,5.635047692307692,5.838233846153846,{"y":6.04142,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.4,3.4040184615384614,3.408036923076923,3.4120553846153845,3.416073846153846,3.4200923076923075,3.424110769230769,3.428129230769231,3.4321476923076926,3.436166153846154,3.4401846153846156,3.444203076923077,3.4482215384615387,{"y":3.45224,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.415,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.317,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.315,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.523,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.628,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.46,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.24,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.4,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€9.49Average Price Target€6.04Lowest Price Target€3.45
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
B. Riley Securities Analyst forecast on DE:M55
Mayank Mamtani
B. Riley Securities
B. Riley Securities
€7.77→€9.49
Buy
162.26%
Upside
Reiterated
08/17/26
MacroGenics price target raised to $11 from $9 at B. RileyMacroGenics price target raised to $11 from $9 at B. Riley
Barclays Analyst forecast on DE:M55
Etzer Darout
Barclays
Barclays
€5.18
Buy
43.05%
Upside
Reiterated
08/14/26
MacroGenics (MGNX) Receives a Buy from Barclays
Stifel Nicolaus Analyst forecast on DE:M55
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
€3.45
Hold
-4.63%
Downside
Reiterated
08/14/26
MacroGenics (MGNX) Gets a Hold from Stifel Nicolaus
TD Cowen Analyst forecast on DE:M55
Tara Bancroft
TD Cowen
TD Cowen
―
Hold
―
Reiterated
08/13/26
Balanced View on MGC026: Early Safety Advantage Offsets Outstanding Efficacy and Market Risks, Supporting Hold Rating
H.C. Wainwright Analyst forecast on DE:M55
Robert Burns
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Agilon Health (NYSE: AGL), Lyell Immunopharma (NASDAQ: LYEL) and MacroGenics (NASDAQ: MGNX)
Roth MKM Analyst forecast on DE:M55
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
€2.59
Buy
-28.48%
Downside
Initiated
09/17/25
MacroGenics (MGNX) Initiated with a Buy at Roth MKM
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
B. Riley Securities Analyst forecast on DE:M55
Mayank Mamtani
B. Riley Securities
B. Riley Securities
€7.77→€9.49
Buy
162.26%
Upside
Reiterated
08/17/26
MacroGenics price target raised to $11 from $9 at B. RileyMacroGenics price target raised to $11 from $9 at B. Riley
Barclays Analyst forecast on DE:M55
Etzer Darout
Barclays
Barclays
€5.18
Buy
43.05%
Upside
Reiterated
08/14/26
MacroGenics (MGNX) Receives a Buy from Barclays
Stifel Nicolaus Analyst forecast on DE:M55
Stephen Willey
Stifel Nicolaus
Stifel Nicolaus
€3.45
Hold
-4.63%
Downside
Reiterated
08/14/26
MacroGenics (MGNX) Gets a Hold from Stifel Nicolaus
TD Cowen Analyst forecast on DE:M55
Tara Bancroft
TD Cowen
TD Cowen
―
Hold
―
Reiterated
08/13/26
Balanced View on MGC026: Early Safety Advantage Offsets Outstanding Efficacy and Market Risks, Supporting Hold Rating
H.C. Wainwright Analyst forecast on DE:M55
Robert Burns
H.C. Wainwright
H.C. Wainwright
―
Hold
―
Reiterated
05/07/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Agilon Health (NYSE: AGL), Lyell Immunopharma (NASDAQ: LYEL) and MacroGenics (NASDAQ: MGNX)
Roth MKM Analyst forecast on DE:M55
Unknown Analyst
Roth MKM
Not Ranked
Roth MKM
€2.59
Buy
-28.48%
Downside
Initiated
09/17/25
MacroGenics (MGNX) Initiated with a Buy at Roth MKM
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ZVRAZevra Therapeutics
ELVNEnliven Therapeutics
DFTXDefinium Therapeutics
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering MacroGenics

3 Months
Etzer DaroutBarclays
Success Rate
9/18 ratings generated profit
50%
Average Return
+3.03%
Copying Etzer Darout's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.03% per trade.
1 Year
Etzer DaroutBarclays
Success Rate
10/18 ratings generated profit
56%
Average Return
+23.94%
Copying Etzer Darout's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +23.94% per trade.
2 Years
Etzer DaroutBarclays
Success Rate
6/18 ratings generated profit
33%
Average Return
-11.14%
Copying Etzer Darout's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -11.14% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

M55 Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
4
4
2
1
1
Buy
1
0
0
1
1
Hold
4
2
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
6
5
5
5
In the current month, M55 has received 2 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. M55 average Analyst price target in the past 3 months is 6.04.
Each month's total comprises the sum of three months' worth of ratings.

M55 Financial Forecast

M55 Earnings Forecast

Next quarter’s earnings estimate for M55 is -€0.27 with a range of -€0.52 to -€0.07. The previous quarter’s EPS was €0.27. M55 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year M55 has Performed in-line its overall industry.
Next quarter’s earnings estimate for M55 is -€0.27 with a range of -€0.52 to -€0.07. The previous quarter’s EPS was €0.27. M55 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year M55 has Performed in-line its overall industry.

M55 Sales Forecast

Next quarter’s sales forecast for M55 is €33.80M with a range of €8.89M to €53.50M. The previous quarter’s sales results were €28.32M. M55 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year M55 has Performed in-line its overall industry.
Next quarter’s sales forecast for M55 is €33.80M with a range of €8.89M to €53.50M. The previous quarter’s sales results were €28.32M. M55 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year M55 has Performed in-line its overall industry.

M55 Stock Forecast FAQ

What is DE:M55’s average 12-month price target, according to analysts?
Based on analyst ratings, MacroGenics’s 12-month average price target is 6.04.
    What is DE:M55’s upside potential, based on the analysts’ average price target?
    MacroGenics has 66.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MacroGenics a Buy, Sell or Hold?
          MacroGenics has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 2 hold ratings and 0 sell ratings.
            What is MacroGenics’s share price target?
            The average share price target for MacroGenics is 6.04. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €9.49 ,and the lowest forecast is €3.45. The average share price target represents 66.89% Increase from the current price of €3.62.
              What do analysts say about MacroGenics?
              MacroGenics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of MacroGenics?
                To buy shares of DE:M55, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.